Age-specific prevalence, incidence of new diagnoses, and drug treatment of attention-deficit/hyperactivity disorder in Germany.
about
Differences in ADHD medication usage patterns in children and adolescents from different cultural backgrounds in the Netherlands.Differences in Speech Recognition Between Children with Attention Deficits and Typically Developed Children Disappear When Exposed to 65 dB of Auditory Noise.An inventory of European data sources for the long-term safety evaluation of methylphenidateTwin and sibling studies using health insurance data: the example of attention deficit/hyperactivity disorder (ADHD).HPV vaccine uptake after introduction of the vaccine in Germany: an analysis of administrative data.Attention-deficit/hyperactivity disorder treatment: what are the long-term cardiovascular risks?Comorbidities in ADHD children treated with methylphenidate: a database studyRegional variation in caesarean deliveries in Germany and its causes.[Use of routine data from statutory health insurances for federal health monitoring purposes].Drug treatment patterns of attention-deficit/hyperactivity disorder in children and adolescents in Germany: results from a large population-based cohort study.Assessment of potential cardiovascular risks of methylphenidate in comparison with sibutramine: do we need a SCOUT (trial)?Outpatient antipsychotic drug use in children and adolescents in Germany between 2004 and 2011.Evaluation of pregnancy outcome records in the German Pharmacoepidemiological Research Database (GePaRD).A randomized controlled multicenter trial on the multimodal treatment of adult attention-deficit hyperactivity disorder: enrollment and characteristics of the study sample.The Risk of Hospitalizations with Injury Diagnoses in a Matched Cohort of Children and Adolescents with and without Attention Deficit/Hyperactivity Disorder in Germany: A Database Study.Challenges in defining the rates of ADHD diagnosis and treatment: trends over the last decade.Nationwide time trends in dispensed prescriptions of psychotropic medication for children and adolescents in Denmark.Is the evidence base of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder flawed?
P2860
Q29353662-544392E9-94CC-4AE0-A9ED-727EFB382740Q30391541-461599A4-BF3E-45A2-83B9-6375792C6192Q30603225-60E74638-33E4-4979-8593-1466E2F1625DQ30620838-8E3BE9ED-5F97-4469-9E31-C05449BA67A5Q30779875-A6D76CA3-07F1-4A77-A682-30D08D43C8CDQ34461113-9B0F1258-605C-4CBB-AED2-A9B8BD98E2D5Q34538107-B86C1538-B45C-48DC-9F27-B5221A34F5B4Q34698837-F479776F-D40F-4A4D-96C5-13419C9C75E0Q35128349-52D94185-DB7A-4C78-921C-4670C6059C43Q36469468-0F739D4B-0D72-43F2-A19A-EC008AFB721EQ38242438-3E8F9E44-05F6-45FB-B80F-F785CE4167ADQ38821689-54493186-3351-44A5-A8C5-2C99189F5ADDQ44140747-20FB54F2-A0DE-4EEA-B42C-5956617423DBQ44268751-EC565512-610A-4A76-AB98-8AAE5C4B2CF2Q45832689-3ED68B38-84AC-4E2B-9DB8-EC7047898D78Q47159089-234232D0-3C31-4E3B-8FE6-02499C63912AQ50559123-2B447FBD-2487-429D-94B6-98FAFCED3A89Q52143533-2444746B-5C9B-4288-8AD0-2DECD84F221C
P2860
Age-specific prevalence, incidence of new diagnoses, and drug treatment of attention-deficit/hyperactivity disorder in Germany.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Age-specific prevalence, incid ...... ractivity disorder in Germany.
@en
type
label
Age-specific prevalence, incid ...... ractivity disorder in Germany.
@en
prefLabel
Age-specific prevalence, incid ...... ractivity disorder in Germany.
@en
P2093
P356
P1476
Age-specific prevalence, incid ...... ractivity disorder in Germany.
@en
P2093
Angela A Kraut
Christina Lindemann
Edeltraut Garbe
Franz Petermann
Ina Schreyer-Mehlhop
Ingo Langner
Tanja Schad-Hansjosten
Ulrike Petermann
P304
P356
10.1089/CAP.2011.0064
P577
2012-08-02T00:00:00Z